ENTERA BIO LTD. Guarantor Obligations, Maximum Exposure, Undiscounted
ENTERA BIO LTD. (ENTX) had Guarantor Obligations, Maximum Exposure, Undiscounted of $60.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Notes
us-gaap:GuaranteeObligationsMaximumExposure · last filed 2026-03-27
- 2025-12-31: Guarantor Obligations, Maximum Exposure, Undiscounted $60.00K.
| Period end | Guarantor Obligations, Maximum Exposure, Undiscounted |
|---|---|
| 2025-12-31 | $60.00K 10-K · filed 2026-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |